One major limitation of this study is that although a previous study has shown that CD169+ macrophages phagocytose dead tumor cells and cross-present tumor antigens to CD8+ T cells for activation in an animal model [11], we were unable to confirm the direct link between dead OSCC cells and CD8+ T cell activation in our model. This evidence concerns the gene SIGLEC1 and neoplasm.